Hepatotoxicity in an African antiretroviral therapy cohort: the effect of tuberculosis and hepatitis B

Abstract

In this African ART cohort, we found a low incidence of and minimal morbidity due to hepatotoxicity. HBsAg and concomitant tuberculosis therapy significantly increased the risk of hepatotoxicity.